First Avenue Ventures

About

Portfolio · 1

Quris-AI

AI-based Drug Development Platform

1 round $19.0M committed Latest: 2022-01

Investment activity

Q&A

What is First Avenue Ventures' primary business model?

First Avenue Ventures operates as a private business incubator.

What is First Avenue Ventures' most notable portfolio company?

First Avenue Ventures' most notable portfolio company is Quris-AI, an AI-based Drug Development Platform founded in 2020.

In which sector does First Avenue Ventures primarily invest?

First Avenue Ventures primarily invests in the Health Tech & Life Sciences sector, with one portfolio company in this area.

What is the typical investment stage for First Avenue Ventures?

First Avenue Ventures typically invests at the Seed stage, with one recorded investment at this stage.

What was the most recent investment activity for First Avenue Ventures?

First Avenue Ventures made an investment in January 2022, which was also when they added a new portfolio company.

What is the typical check size range for First Avenue Ventures?

First Avenue Ventures' investment range is between $19M and $19M.

Has First Avenue Ventures led any investment rounds?

According to startupim data, First Avenue Ventures has a 0% lead investor share, indicating they have not led any investment rounds.

What is the exit ratio for First Avenue Ventures?

First Avenue Ventures has an exit ratio of 0%, meaning they have not had any recorded exits.